Hoyin Chu

机构：Broad Institute, Memorial Sloan Kettering Cancer Center, Harvard University, Cornell University, Tri-Institutional PhD Program in Chemical Biology, Dana-Farber Cancer Institute · ORCID：0000-0001-8630-3667

发表论文 29 篇 · 总被引 236 次 · h-index 8

代表论文

• CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods (2024 · Genome biology · 被引 63)
• Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling (2025 · Nature Methods · 被引 18)
• Population-scale sequencing resolves determinants of persistent EBV DNA (2026 · Nature · 被引 14)
• Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS) (2025 · Nature Communications · 被引 14)
• Integrative Analysis of Germline Rare Variants in Clear and Non–clear Cell Renal Cell Carcinoma (2024 · European Urology Open Science · 被引 9)
• Sequence and structural determinants of efficacious de novo chimeric antigen receptors (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 6)